-
Bingnan earned his BSc (Hons) in Biochemistry from the University of Liverpool and his Sc.M. in Molecular Microbiology and Immunology from the Johns Hopkins Bloomberg School of Public Health. He joined the Hardwick Lab in the winter of 2024, where he studied cell death mechanisms in clinical isolates of Cryptococcus neoformans. Bingnan plans to begin his Ph.D. studies in Fall 2027 and hopes to broaden his research to other microbial pathogens while further exploring microbial pathogenesis and host–pathogen interactions.
-
Jyotsna graduated from the Molecular Microbiology and Immunology program in 2026 after completing her thesis research in the Hardwick Lab. Her work examined death resistance and intracellular persistence of Cryptococcus neoformans in mammalian macrophages. She now works at the U.S. Food and Drug Administration as a Regulatory Scientific Reviewer, evaluating neurological and acute stroke medical devices to help ensure their safety and effectiveness.
